Fingerprint
Dive into the research topics of 'Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study
Rita Nanda*, Laura Q.M. Chow, E. Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, Vassiliki Karantza, Laurence Buisseret
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
1276
Scopus
citations